[Table/Fig-3]:
Loose motion duration before presentation (days) | Antibiotic (used or not/WHO protocol followed or not) | Total | |||
---|---|---|---|---|---|
Used but deviated | Not used but followed # | Used and followed # | |||
1 to 3 | No. | 23 | 200 | 37 | 260 |
% | 8.8% | 76.9% | 14.3% | 100.0% | |
4 to 6 ^ | No. | 10 | 89 | 14 | 113 |
% | 8.8% | 78.8% | 12.4% | 100.0% | |
7 &> ^ | No. | 16 | 5 | 8 | 29 |
% | 55.2% | 17.2% | 27.6% | 100.0% | |
Total | No. | 49 | 294 | 59 | 402 |
% | 12.2% | 73.1% | 14.7% | 100.0% | |
Chi-Square Tests | Value | df | p-value | Association is- | |
Pearson Chi-Square $ | 64.493 | 4 | 3.29× 10-13 | Significant | |
Pearson Chi-Square ^, # | 7.593 | 1 | 0.006 | Significant |
$ 2 cells (22.2%) have expected count less than 5. ^, # Row & Column data pooled & Chi-Square Test reapplied with Continuity Correction.